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Background: The Glasgow Benefit Inventory (GBI) is a
validated, generic patient-recorded outcomemeasure widely
used in otolaryngology to report change in quality of life
post-intervention.
Objectives of review: To date, no systematic review has
made (i) a quality assessment of reporting of Glasgow
Benefit Inventory outcomes; (ii) a comparison between
Glasgow Benefit Inventory outcomes for different inter-
ventions and objectives; (iii) an evaluation of subscales in
describing the area of benefit; (iv) commented on its
value in clinical practice and research.
Type of review: Systematic review.
Search strategy: ‘Glasgow Benefit Inventory’ and ‘GBI’
were used as keywords to search for published, unpublished
and ongoing trials in PubMed, EMBASE, CINAHL and
Google in addition to an ISI citation search for the original
validating Glasgow Benefit Inventory paper between 1996
and January 2015.
Evaluation method: Papers were assessed for study type
and quality graded by a predesigned scale, by two
authors independently. Papers with sufficient quality
Glasgow Benefit Inventory data were identified for
statistical comparisons. Papers with <50% follow-up were
excluded.
Results: A total of 118 eligible papers were identified for
inclusion. A national audit paper (n = 4325) showed that
the Glasgow Benefit Inventory gave a range of scores
across the specialty, being greater for surgical intervention
than medical intervention or ‘reassurance’. Fourteen
papers compared one form of surgery versus another form
of surgery. In all but one study, there was no difference
between the Glasgow Benefit Inventory scores (or of any
other outcome). The most likely reason was lack of
power. Two papers took an epidemiological approach and
used the Glasgow Benefit Inventory scores to predict
benefit. One was for tonsillectomy where duration of sore
throat episodes and days with fever were identified on
multivariate analysis to predict benefit albeit the precision
was low. However, the traditional factor of number of
episodes of sore throat was not predictive. The other was
surgery for chronic rhinosinusitis where those with polyps
on univariate analysis had greater benefit than those
without. Forty-three papers had a response rate of >50%
and gave sufficient Glasgow Benefit Inventory total and
subscales for meta-analysis. For five of the 11 operation
categories (vestibular schwannoma, tonsillectomy,
cochlear implant, middle ear implant and stapes surgery)
that were most likely to have a single clear clinical
objective, score data had low-to-moderate heterogeneity.
The value in the Glasgow Benefit Inventory having both
positive and negative scores was shown by an overall
negative score for the management of vestibular schwan-
noma. The other six operations gave considerable
heterogeneity with rhinoplasty and septoplasty giving the
greatest percentages (98% and 99%) most likely because
of the considerable variations in patient selection. The
data from these operations should not be used for
comparative purposes. Five papers also reported the
number of patients that had no or negative benefit, a
potentially a more clinically useful outcome to report.
Glasgow Benefit Inventory subscores for tonsillectomy
were significantly different from ear surgery suggesting
different areas of benefit
Conclusions: The Glasgow Benefit Inventory has been
shown to differentiate the benefit between surgical and
medical otolaryngology interventions as well as ‘reassur-
ance’. Reporting benefit as percentages with negative, no
and positive benefit would enable better comparisons
between different interventions with varying objectives
and pathology. This could also allow easier evaluation of
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factors that predict benefit. Meta-analysis data are now
available for comparison purposes for vestibular schwan-
noma, tonsillectomy, cochlear implant, middle ear
implant and stapes surgery. Fuller report of the Glasgow
Benefit Inventory outcomes for non-surgical otolaryn-
gology interventions is encouraged.
Patient-recorded outcome measures
Patient-recorded outcome measures are used across surgical
specialties to provide quantitative measures of the impact of
interventions on patients’ health-related quality of life.1–3 In
otolaryngology, there is a wide range of operative proce-
dures, many of which are elective with the primary objective
to improve the quality of life. Multiple symptom or disease-
specific questionnaires are used in otolaryngology practice
for departmental audit and research to assess a symptom,
disease or procedure, for example Sino Nasal Outcome Test
(SNOT-22)4 and Voice Symptom Scale.5 However, the
results of these questionnaires are not comparable across
different patient groups and conditions. Given the hetero-
geneous nature of interventions in otolaryngology, a patient-
completed questionnaire that can be used universally for all
otolaryngology conditions and management options would
be valuable. The EQ-5D,6HUI-37 and SF-368 are examples of
such generic questionnaires that are used routinely in
assessing health-related quality of life outcome of surgeries
across all specialties. There is concern that these
questionnaires may not be sensitive enough to pick up
health-related quality of life changes post-otolaryngology
intervention.
The Glasgow Benefit Inventory
The Glasgow Benefit Inventory (GBI) is a generic patient-
recorded outcome measure that was reported by Robinson
et al. in 19969 and has gained widespread popularity in
otolaryngology. The Glasgow Benefit Inventory is designed
for use only once post-intervention, as a measure of
change related to a specific surgical or medical interven-
tion. The questionnaire, which can be completed by
interview or self-completed by patients, consists of 18
questions answered using a five-point Likert scale,
addressing change in health status post any intervention.
The responses are then scaled and averaged to give a score
with a range 100 (poorest outcome) through 0 (no
change) to +100 (best outcome).10 The original validating
procedures were for hearing [middle ear surgery, n = 181
(response rate 64%), cochlear implant, n = 184 (response
rate 86%)], eradicating ear activity [mastoid procedures,
n = 138 (response rate 72%)], nasal blockage and disfig-
urement [rhinoplasty, n = 96 (response rate 43%)] and
pharyngeal surgery [tonsillectomy, n = 61 (response rate
60%)]. Principal component analysis found that questions
from the Glasgow Benefit Inventory were subdivided and
loaded reliably onto three distinct subscales. Twelve
questions focused on general changes in health status, as
well as changes in psychosocial health status were termed
‘General’. A further three questions were related to the
amount of social support needed in relation to the condition
being questioned (social). The remaining three questions
addressed changes in physical health status including
medications requirement and number of visitations to
doctors required (physical). These subscales were used to
elicit the profile of improvement across Glasgow Benefit
Inventory scores and interventions. In order to prove a
patient-recorded outcomemeasure is acceptable, it has to be
valid, reliable and sensitive to change; for the five interven-
tions in the original Glasgow Benefit Inventory paper, both
total and subscale scores fulfilled these criteria.
While acceptability of the Glasgow Benefit Inventory is
widespread in otorhinolaryngology, no review has been
performed of its use. In particular, we have no knowledge
on the quality of the data that are being reported.
Therefore, to date, no conclusions to add to the original
validating paper9 regarding the value of the Glasgow Benefit
Inventory as a patient-recorded outcome measure can be
reached. In addition, the original paper assessed the
Glasgow Benefit Inventory measured by principal compo-
nent analysis to give three subscales. However, we do not
know whether these vary between interventions and their
clinical objectives.
In summary, a systematic review of papers that use the
Glasgow Benefit Inventory as a patient-recorded outcome
measure is reported. From this, we aim to estimate the
current applicability and limits of this widely used patient-
recorded outcome measure.
Methodology
Search methods
‘Glasgow Benefit Inventory’ and ‘GBI’ were used to perform
a search for published and unpublished and ongoing trials
in PubMed, EMBASE, CINAHL and Google from the
inception of the Glasgow Benefit Inventory (1996) to
January 2015. In addition, a citation search from the
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original validating paper was used from the ISI Citation
search engine.
Selection of studies
The PRISMA flow chart Fig. 1 records the selection process.
Once eligible papers (n = 118) had been identified, their
study designwas categorised.No evaluations of the quality of
these papers were made apart from the percentage of study
patients in whom the Glasgow Benefit Inventory was
reported. An initial cut-off point for low follow-up quality
was set at 50%and subsequently confirmed to be appropriate
from a histogram of percentage response rate against
number of papers. Ten papers that had a follow-up rate of
<50%were considered to be of insufficient follow-up quality
for data reporting.11–20 A further paper which included
multiple conditions with n < 10 was also excluded.21
Data extraction and management
Two authors (JH and GGB) undertook independent
assessment of the screened 118 papers using a piloted
pro forma. Type of study, pathology, aim of interven-
tion, response rate and use of other patient-recorded
outcome measures were included. All data available on
Glasgow Benefit Inventory reporting were recorded for
total and subscale scores, including calculation of
summary data from figures and raw data when results
not available.
Completeness of reporting of the Glasgow Benefit
Inventory data
Papers were assessed to identify those with sufficient
Glasgow Benefit Inventory data for comparison purposes.
Fig. 1. PRISMA Statement of search strategy and inclusion and exclusion criteria.
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1 Sufficient: Adult cohort. Subscales reported. Distribution
of individual data given.22–64
2 Low grade: Children in cohort and not reported sepa-
rately. No subscales reported. Mean total score data only
given.65–129
Data analysis
Given the heterogeneous nature of otolaryngology interven-
tions, each was allocated to one of the following:
1 Interventions for hearing (bone-anchored hearing aid,
cochlear implant, middle ear implant, stapes surgery).
2 Interventions for benign tumours (vestibular schwan-
noma).
3 Interventions for nasal function (septoplasty for nasal
obstruction and endoscopic sinus surgery for chronic
sinusitis).
4 Interventions for epiphora (dacryocystorhinostomy).
5 Interventions for cosmesis (rhinoplasty and auricular
reconstruction/otoplasty).
6 Interventions for chronic tonsillitis (tonsillectomy).
7 Interventions for snoring.
8 Interventions for dystonia (botulinum toxin).
Data synthesis
Studies were allocated as above into subgroups based on the
clinical aim of intervention. Forest plots were constructed
(Excel, Microsoft Office, 2011) and REVIEW MANAGER (REV-
MAN Version 5, RevMan 5.2, Cochrane Group), with scores
weighted for size of study. Heterogeneity (chi-squared) was
tested for within intervention aims and subscales using
REVMAN 5. Heterogeneity was deemed moderate to high if
total score heterogeneity was ≥30% with a significant chi-
squared test. For some intervention aims (endoscopic sinus
surgery and snoring surgery), meta-analysis was not relevant
as only one paper was available on each. Mean total, general,
social and physical subscale scores were analysed using one-
way ANOVA in SPSS (IBM, version 22, SPSS v22, IBM, New
York, USA) across interventions with low heterogeneity with
post hocGames–Howell testing usedwhen significance across
interventions was P < 0.05.
Results
After screening, 118 articles were assessed for eligibility
(Fig. 1). A systematic review of Glasgow Benefit Inventory
scores following tonsillectomy was the only quality-of-life
review identified129 and included no additional studies
beyond those included separately below. No reviews with
new data directly relating to the Glasgow Benefit Inventory
were identified.
Audit papers
One paper was a national audit of both surgical and medical
outcomes including ‘reassurance’ in 4235 adult patients.66
The Glasgow Benefit Inventory scores were a secondary
outcome, and only reported as means, but these did
indicate that there was such a range of scores that
departmental and personal audit would have to be
controlled for case mix if comparisons are going to be
made between departments and clinicians. All categories of
surgery and medical intervention had a change in health
status on the Glasgow Benefit Inventory with surgical
interventions giving greater benefit compared to medical
treatment or reassurance. Co-incidentally, the primary
outcome of change in HUI-3 was found not to be applicable
as a generic outcome measure for otolaryngology interven-
tions as it was only with otological interventions was there a
change in health status.
A further audit paper reported a department’s Glasgow
Benefit Inventory outcomes following endoscopic sinus
surgery without categorising what the surgery or pathology
was.118
Epidemiological papers
Two papers used the Glasgow Benefit Inventory scores to
identify predictors of benefit. Koskenkorva et al.,44 using
multifactorial analysis, found that number of days with sore
throat and the number of days with fever, rather than the
number of sore throats were the predictive factors that could
predict quality-of-life outcomes. Even then, the precision of
these factorswas low. Salhab et al.40 found that on univariate
analysis, patients with nasal polyps associated with their
chronic rhinosinusitis were significantly more likely to
benefit than those without polyp in the total and general
subscales (Total 18 versus 5, P = 0.045, General 25 versus 8,
P = 0.02).
Validating case series
Six studies attempted to validate the Glasgow Benefit
Inventory against another patient-recorded outcome mea-
sure.34,35,46,54,121,127 Five of these compared with another
patient-recorded outcome measure35,46,54,121,127 (Fairley
Nasal Questionnaire (FNQ), Blepharospasm Disability
Index (BDSI), HUI 3, OMDQ 25). In only one paper was
there an attempt to compare the Glasgow Benefit Inventory
with a patient-recorded outcome measure Hearing Dis-
ability and Handicap Scale (HDHS) and objective testing of
hearing outcomes.34 There was no significant correlation
between HDHS and hearing or Glasgow Benefit Inventory
and hearing.
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Comparative papers
Fourteen papers11,36,37,47–49,53,64,83,88,92,95,98,119 compared
one type of surgery against another type of surgery for the
same condition. In nonewas a power analysis reported of the
numbers required having each operation to show a differ-
ence. Only one of these papers36 was a single-blind
randomised trial. In 13 of the 14 case series, there was no
difference in the Glasgow Benefit Inventory scores between
operations nor in any other outcome. The number of
patients in these case series was ~30–40 for each operation
and thus almost certainly underpowered. Myrseth et al.49
found better outcomes in gamma knife radio surgery versus
microsurgery at 2 years in total (3.2 versus 10.7), general
(0.3 versus 17.2) and physical (5.3 versus 10.0) scales.
Case series
A total of 94 papers reported uncontrolled case series of an
operation, the majority of these being otological. All
intervention aims had a mean positive total Glasgow Benefit
Inventory ranging between 16.5 and 43.9, except for
intervention for benign tumour (vestibular schwannoma),
which had an overall negative score of 4.8. There were
significant differences across the range of interventions (low
heterogeneity) in total, general, social and physical support
subscales (ANOVA F = 103.5-P < 0.001, F = 68.2-P < 0.001,
F = 4.2-P 0.02, and F = 46.2-P < 0.001.)
Data analysis
All the above papers, bar the two audit papers,66,118 had
Glasgow Benefit Inventory data of a specific operation that
could be used for comparison purposes and data synthesis.
Initial analysis of the quality criterion of at least a 50%
response rate to indicate studies of quality showed that this
was a valid cut-off point. Using this criterion, 43 of the 118
(36%) papers had sufficient quality of Glasgow Benefit
Inventory data and a follow-up rate of at least 50% to be
included in quantitative analysis. All papers reported a
surgical intervention, and these were grouped into 12
categories of the aims of surgery.
The characteristics of these papers are grouped according
to the predicted aim of the intervention in Table 1. The
heterogeneity between intervention scores is detailed in
Table 2.Where heterogeneity was deemed to bemoderate to
high (>30% in total and or subscale, with significant chi-
squared test), it was considered these were too great for the
combined data to be reported. This applied to septoplasty,
rhinoplasty, otoplasty, dacryocystorhinostomy and botuli-
num therapy with septoplasty and rhinoplasty giving the
greatest heterogeneity (98% and 99%). The most likely
reasons for this are the heterogeneity of the pathology and
multiple surgical objectives.
For cochlear implant, middle ear implant, stapes surgery,
vestibular schwannoma interventions and tonsillectomy,
there was minimal-to-nil heterogeneity and scores are
representative of intervention (Fig. 2 and Table 3). It is of
note that the objective/s of these interventions are narrower
than the other interventions. An attempt was made to
narrow the objectives of bone-anchored hearing aid taking
out the paper by Faber et al.27 which reported its use
for single-sided deafness but this did not lessen the
heterogeneity.
Where papers did not fit into easily defined categories or
intervention or pathology, it was felt that combining these
would only add heterogeneity. Therefore, these eight
papers are reported in Table S1 and will not be further
analysed.55,57–60,62,63,71
Comparative intervention analysis
Between interventions for vestibular schwannoma (micro-
surgery n = 159, gamma knife radiosurgery n = 154, radio-
therapy n = 42, and n = 36 observation), there was no
significant difference in total score (F = 1.8, P = 0.26),
general (F = 4.75, P = 0.06), physical (F = 0.96, P = 0.48)
and social support score (F = 3.8, P = 0.09). The total
numbers for each of the interventions clinically support this
finding of no difference. Overall, there are negative scores for
total, general and physical subscales reflecting worsening of
quality of life for this pathology across the range of
interventions (Fig. 3).
Percentage benefit
Five papers reported, as well as the mean Glasgow Benefit
Inventory data, the percentage of patients that had no or
negative benefit. Three of these were for management of
vestibular schwannoma48,49,51 which mirrored the negative
mean Glasgow Benefit Inventory totals score [4.8 (9.4,
32.8)] of all the different management strategies for that
condition.
Martin et al.87 describe a case series of 54 patients given a
bone-anchored hearing aid for single-sided deafness, five
were non-users because of negative benefit, a further three
continued usage despite reporting negative benefit and six
continued to use but without any benefit. So overall, 14 of 54
(30%) patients had no or negative benefit with a bone-
anchored hearing aid for single-sided deafness.
Kyrodimos et al.76 reported 30 patients following
intratympanic gentamicin for Meniere’s disease and nine
patients (50%) expressed an overall Glasgow Benefit Inven-
tory benefit, while 6 (33%) expressed no benefit and three
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Table 1. Included papers with adequate quality Glasgow Benefit Inventory reporting by intervention (N = 39)
Paper Question Paper type
Response
number (%) Reporting
Reporting of other
scores
Bone-anchored hearing aid
Arunachalam
et al.22
Bone-anchored hearing
aid as a unilateral hearing
aid
Case series 51 (85) Mean, Cochlear implant of
total and subscales
Nil
De Wolf et al.23 Bone-anchored hearing
aid in older hearing aid
users, as a conventional
unilateral hearing aid
Case series 134 (80) Mean and SD for total and
subscales, derived
cochlear implant
PTA
APHAB
NCIQ
HHIE S
Faber et al.27 Bone-anchored hearing
aid in the elderly with
single sided deafness
Case series 11 (100) Mean and SD for total and
subscales, derived
cochlear implant
APHAB CROS
HHIE-S
Gillet et al.24 Bone-anchored hearing
aid as a conventional
hearing aid
Case series 41 (60) Individual score data.
Mean, cochlear implant
derived for total and
subscales
Nil
Ho et al.25 Bone-anchored hearing
aid, effect of bilateral aid
Case series 71 (76) Mean, cochlear implant,
Range for total and
subscales
PTA
HINT
Ricci et al.26 Bone-anchored hearing
aid: children and adults
for unilateral disease
Case series 16 adults (96) Individual score data.
Mean, cochlear implant
derived for total and
subscales
PTA
Wilkie et al.61 Bone-anchored hearing
aid: Osseointegrated
hearing implant surgery
Case series 30 (100) Mean with cochlear
implant for total and
subscale data
Cochlear implant
Bonnard et al.28 Cochlear implant: bilateral
cochlear implants and
digisonic binaural
cochlear implant
Case series 13 (87) Mean with SD for total and
subscales, derived
cochlear implant
Speech perception
and localization,
APHAB
Galindo et al.29 Fine structure processing
improves telephone
speech perception in
cochlear implant users
Case series for
Glasgow
Benefit
Inventory data
19 (50) Mean with SD for total and
subscales, derived
cochlear implant
Fabers
questionnaire
Free-field
audiometry
Vermeire et al.30 Cochlear implant: Benefit
in the elderly,
post-lingually deafened
Case series 81 (91) Mean with SD for total and
subscales, cochlear
implant derived
HHIA
Middle ear implant
Mosnier et al.31 Benefit of VSB in patients
implanted for 5–8 years
Case series 62 (81) Mean with SEM, cochlear
implant derived for total
and subscales
PTA
Schmuziger
et al.32
Long-term outcome of
VSB
Case series 20 (83) Mean with cochlear
implant for total and
subscales
PTA
Stapes surgery
Konstantinidis
et al.33
Causse laser stapedotomy Case series 34 (76) Mean with cochlear
implant for total and
subscales
Air bone gap
Subramaniam
et al.34
Hearing outcomes after
stapes surgery
Validating case
series
21 (65) Mean, SD for total and
subscales, derived
cochlear implant
HDHS
PTA
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Table 1. continued
Paper Question Paper type
Response
number (%) Reporting
Reporting of other
scores
Septoplasty
Akduman
et al.64
Surgical management of
nasal obstruction
Case series 134 (100) Septoplasty only group –
Mean and SD for total and
subscales, derived
cochlear implant
NOSE
Konstantinidis
et al.35
Outcomes of nasal septal
surgery
Validating case
series
26 (76) Above criterion results –
Mean, median, range and
SD for total and subscales,
cochlear implant derived
FNQ
Uppal et al.46 Nasal septal surgery for
obstruction
Validating case
series
62 (75) Mean with SD for total and
subscales, cochlear
implant derived
NSS
Dacryocystorhinostomy
Hii et al.37 Dacryocystorhinostomy:
External versus endonasal
Comparative
series
68 (86) Mean with cochlear
implant, for total and
subscales
Nil
Spielmann
et al.38
Dacryocystorhinostomy:
Endonasal
Case series 92 (71) Mean and cochlear
implant for total and
subscales
Nil
Yeniad et al.39 Dacryocystorhinostomy:
transcanalicular bilateral
Dacryocystorhinostomy
with a diode laser
Case series 38 (100) Mean with cochlear
implant for total and
subscales
Nil
Endoscopic sinus surgery
Salhab et al.40 ESS: polyposis versus
sinusitis
Comparative
series
77 (63) Median and IQR for total
and subscales
Nil
Rhinoplasty
Chauhan et al.41 Adolescent rhinoplasty Case series 30 (100) Mean with SD and cochlear
implant for total and
subscales
Nil
Draper et al.42 Rhinoplasty Case series 51 (65) Mean with SD and cochlear
implant for total and
subscales
Nil
Otoplasty
Braun et al.52 Otoplasty using suture
techniques
Case series 21, adults (74) Mean, median, SD and
cochlear implant for total
and subscales
Nil
Braun et al.43 Auricular reconstruction Case series 45, adults (83) Mean, median, SD, for total
and subscales, cochlear
implant derived
Nil
Tonsillectomy
Koskenkorva
et al.44
Tonsillectomy: predictive
factors for QOL
improvement
Case series 142 (93) Median total and subscales
with confidence intervals
derived from graphs
Nil
Koskenkorva
et al.45
Tonsillectomy: QOL in
adults
Case series 62 (89) Mean and SD for total and
subscales, cochlear
implant derived
Nil
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Table 1. continued
Paper Question Paper type
Response
number (%) Reporting
Reporting of other
scores
Snoring surgery
Uppal et al.36 Laser palatoplasty versus
uvulectomy with
punctate palatal
diathermy
RCT, single
blind
62 (75) Mean, SD, SEM for total and
subscales, cochlear
implant derived
Snoring score
Vestibular schwannoma
Brooker et al.47 Vestibular schwannoma:
microsurgery, radiation
or observation
Comparative
series
229 (66) Mean, SD and better/worse
for totals and subscales,
cochlear implant derived
SF-12
Iyer et al.48 Hearing preservation
effects post vestibular
schwannoma surgery
Comparative
series
83 (80) Mean, and cochlear
implant for total and
subscales
SF-36
Myrseth et al.49 Vestibular schwannoma:
surgery or GKRS
Comparative
series
80 (87) Mean, SD, range for total
and subscales, cochlear
implant derived
SF36
Tinnitus and
vertigo
VAS
Subramaniam
et al.50
Unilateral profound
hearing loss and CPA
surgery
Case series 51 (93) Mean and cochlear
implant for total and
subscales
Hearing
outcomes
Timmer et al.51 Vestibular schwannoma:
GKRS
Case series 97 (91) Mean, SD, range for total
and subscale cochlear
implant derived
SF 36
Audio-
vestibular
symptoms
Botulinum toxin
Bhattacharyya
et al.53
Botulinum toxin for
spasmodic dysphonia
and OMD
Comparative
series
23 (74) Mean with cochlear
implant for total and
subscales
Nil
Merz et al.54 Botulinum for OMD Validating case
series
25 (83) Mean with SD for total and
subscales, cochlear
implant derived
OMD-25
Miscellaneous
MacAndie
et al.55
Botulinum for essential
blepharospasm
Case series 36 (82) Mean and cochlear
implant for total and
subscales
Nil
Banerjee et al.56 Intratympanic gentamicin
for Meniere’s
Case series 17 (81) Mean and cochlear
implant for total and
subscales
Nil
Potter et al.57 Canalplasty for chronicOE Case series 13 (93) Mean and cochlear
implant for total and
subscales
PTA
Leong et al.58 Endoscopic stapling of
Zenker’s diverticulum
Case series 32 (74) Mean, SD and cochlear
implant for total and
subscales
Nil
Hempel et al.59 Outer ear canal surgery for
exostoses
Case series 39 (77) Mean, SD, Range and
cochlear implant for total
and subscales
Nil
Hill et al.60 Collagen vocal cord
augmentation for
Hypophonia in
Parkinson’s’ patients
Case series 12 (71) Mean, SD and cochlear
implant for total and
subscales
Nil
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patients (17%) complained of a negative effect of the
intervention.
An additional paper by Koskenkorva et al.44 reported
negative Glasgow Benefit Inventory benefit score of – 20 in
one of 142 tonsillectomy patients, and from their distribu-
tion graphs, a further five patients had no benefit giving an
overall no or negative benefit rate for tonsillectomy of 4%.
Discussion
Summary of findings
TheGlasgowBenefit Inventory has been popularised since its
design and used as a generic patient-recorded outcome
measure in over 100 surgical studies for otorhinolaryngo-
logical conditions.
Fourteen papers compared one surgical intervention
against another procedure for a specific condition but in
only one paper on surgery for vestibular schwannoma was it
possible to show a statistically significant difference in the
Glasgow Benefit Inventory scores at 2 years follow with
greater benefit from gamma knife radiosurgery versus
conventional micro-surgery. Interestingly, none of the other
outcomes in these 14 papers was able to show a difference in
greater than one of the subscales.
Two studies used the total Glasgow Benefit Inventory
scores to identify factors to predict benefit, one of the most
clinically useful aspects of having a patient-recorded out-
come measure outcome as the predictive factor.
A quantitative analysis of Glasgow Benefit Inventory
scores from surgery for ear, nose and throat conditions with
12 different aims of intervention is reported after charac-
terising the study design and grading the quality of the
evidence for completeness of follow-up. Where several case
series were of the same surgical procedure, forest plots were
performed of the Glasgow Benefit Inventory total and
Table 1. continued
Paper Question Paper type
Response
number (%) Reporting
Reporting of other
scores
Mahroo et al.62 Outcomes of ptosis
surgery over time
Case series 50 (79) Mean and SD for total and
subscales with cochlear
implant derived
Nil
Crosbie et al.63 Meatoplasty and
tympanoplasty for
chronic OE
Case series 16 (84) Mean, SD and cochlear
implant for total and
subscales
Nil
PTA, Pure tone audiogram; APHAB, Abbreviated profile of hearing aid benefit; NCIQ, Nijmegen cochlear implantation questionnaire;
HHIE S, Hearing handicap inventory for the elderly [screening version]; CROS, Contralateral routing of signal; HINT, Hearing in noise
testing; HHIA, Hearing handicap inventory; NOSE, Nasal obstruction and septoplasty effectiveness; QOL, Quality of life; GKRS, Gamma
Knife Radiosurgery; CPA, Cerebellopontine angle; OMD, Oromandibular dystonia; OE, Otitis externa.
Table 2. Heterogeneity across interventions by score, measured by inconsistency (I2) and chi-squared testing. Interventions with asterisk
were deemed to have moderate-to-significant heterogeneity
Intervention
Total score
heterogeneity
(I2) (P-value v2)
General score
heterogeneity
(I2) (P-value v2)
Social score
heterogeneity
(I2) (P-value v2)
Physical score
heterogeneity
(I2) (P-value v2)
Moderate-to-
significant
heterogeneity
Bone-anchored
hearing aid
57% (0.02) 62% (0.01) 35% (0.12) 70% (0.01) *
Cochlear implant 9% (0.33) 26% (0.26) 0% (0.54) 36% (0.21)
ME 0% (0.45) 0% (0.89) 65% (0.07) 69% (0.07)
Stapes 0% (0.71) 0% (0.99) 14% (0.28) 0% (0.65)
Vestibular schwanoma 38% (0.12) 55% (0.09) 69% (0.01) 34% (0.14)
Tonsils 0% (0.69) 34% (0.22) N/A 40% (0.20)
Septal 99% (<0.01) 67% (0.01) 99% (<0.01) 91% (0.01) *
Dacryocystorhinostomy 76% (0.01) 84% (<0.01) 70% (0.02) 82% (<0.01) *
Rhinoplasty 98% (<0.01) 99% (<0.01) 94% (<0.01) 54% (0.14) *
Otoplasty 60% (0.09) 64% (0.09) 0% (0.77) 65% (0.09) *
Botulinum 70% (0.04) 79% (0.01) 85% (0.01) 65% (0.06) *
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(a) (b)
(c) (d)
Fig. 2. Interventions for hearing (a–c): cochlear implant, middle ear implant (MEI) and stapes surgery. Intervention for tonsils (d). Forest
plot of intervention for hearing and tonsils data with low heterogeneity: boxes represent mean score with lines for 95% confidence intervals.
Summary (diamond) shows mean score with 95% confidence interval.
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principal component subscores to better define the confi-
dence intervals. The heterogeneity between such case series
varied considerably between 0% and 99%. However, it was
evident that where the surgery could only be for a very
specific aim, such as cochlear implantation and tonsillec-
tomy, then the heterogeneity was sufficiently acceptable to
give meta-analysis data of value for audit purposes.
One advantage of the Glasgow Benefit Inventory is that it
has both positive and negative scores. This was evident in the
management of patients with vestibular schwannoma where
the overall total Glasgow Benefit Inventory score was 5.1
(13.1, 3.0), and there being no difference between obser-
vation and the three categories of active intervention. Our
recommendation is that the percentages of patients that
benefitted, had no benefit or were worse after a procedure be
routinely reported. Such Glasgow Benefit Inventory data
could be more clinically useful than the current mean and
standard deviation data being the method most commonly
used. To date, such data are only available from five case
series.
The analysis of case series data showed material hetero-
geneity for most surgical procedures and the large Scottish
National audit of otorhinolaryngological practice likewise
had a wide range of mean Glasgow Benefit Inventory scores
from reassurance to surgery. As such, departmental audit or
individual audit of surgical practices should not have
Glasgow Benefit Inventory as the main clinical outcome
unless controlled for the case mix.
Review strengths
As a systematic review, quality of reporting of the
Glasgow Benefit Inventory scores from the literature
identified was used with a cut-off of >50% of loss to
follow-up being used and justified by the distribution
analysis. From eligible papers, the Glasgow Benefit
Inventory data reported varied in extent but where it
could be used, such as in the comparison between the
scores between aims of intervention, it was included.
Apart from identifying large numbers of surgical case
series reporting the Glasgow Benefit Inventory scores, one
paper demonstrated its use to identify factors predicting
benefit.44
Review limitations
The majority of the literature reports surgical series. The
majority of patients referred to otorhinolaryngological
clinics are not managed surgically. Even those managed
surgically could be managed otherwise. So the Glasgow
Benefit Inventory scores of patients managed non-surgi-
cally are important to have comparisons with. As much
Glasgow Benefit Inventory data were included in the
analysis as possible but many papers had to be excluded
because the results were displayed graphically from which
numerical data could not be assessed. It was not considered
viable to request further data from study authors as the
majority were written by trainees’ in non-research estab-
lishments. What was searched for and not identified except
in five papers48,51,76,87,98 were reports of the percentage of
patients for whom there was no or negative benefit of
surgery. This could be one of the main strengths of the
Glasgow Benefit Inventory scoring system that must be
further investigated as it is with such percentages that
differences between interventions or their aims could
become more obvious.
Table 3. Mean outcome scores of included quantitative analysis studies for interventions with low heterogeneity, N = 19, n = 816
Paper type
Number of studies, N
Number of patients, n
Glasgow Benefit
Inventory
Total
Mean (95% CI)
Glasgow Benefit
Inventory
General
Mean (95% CI)
Glasgow Benefit
Inventory
Social support
Mean (95% CI)
Glasgow Benefit
Inventory
Physical
Mean (95% CI)
Cochlear implant
N = 3, n = 113
38.4 (29.0, 47.9) 50.7 (38.9, 62.1) 20.1 (9.8, 33.8) 5.0 (2.2, 14.2)
ME
N = 2, n = 100
16.3 (10.4, 22.1) 22.5 (14.7, 30.2) 9.6 (3.1, 14.2) 2 (5.47, 2.1)
Stapes
N = 2, n = 55
29.9 (21.0, 38.7) 42.7 (33.8, 48.6) 5.3 (0.2, 10.0) 3.5 (5.2, 11.0)
Vestibular schwanoma
N = 5, n = 482
4.8 (9.4, 2.7) 11.2 (17.2, 5.9) 17.6 (12.7, 22.5) 3.6 (8.3, 0.6)
Tonsils
N = 2, n = 66
27 (20.3, 32.8) 21.5 (14.5, 29.2) 2.5 (0.8, 4.2) 68 (46.9, 80)
Comparison across
interventions
F = 103.5, P < 0.001 F = 68.2, P < 0.001 F = 4.2, P = 0.02 F = 46.2, P < 0.001
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Fig. 3. Intervention for vestibular schwannoma: boxes represent mean score with lines for 95% confidence intervals. Summary (diamond)
shows mean score with 95% confidence interval. Five studies were included in analysis for quality of life post-intervention for vestibular
schwannoma (VS). Iyer et al.48 reported a comparative series of outcome following surgery via the translabyrinthine (TL) approach versus
middle fossa (MF) approach. Subramaniam et al.50 and Timmer et al.51 described a case series on outcomes following microsurgery and
gamma knife radio surgery (GKRS), respectively. Brooker et al.47 report a three-arm comparative series of microsurgery, radiation and
observation. Myrseth et al.49 undertook a comparative series of surgery versus GKRS.
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Implications for clinical practice and research
This review has highlighted the absence of any recom-
mended method of reporting Glasgow Benefit Inventory
data. This has stimulated the creation of a MRCHI
website10 which will be regularly updated. The 118 papers
identified reporting Glasgow Benefit Inventory outcomes,
in retrospect, have all weaknesses in method of reporting
the data. The Glasgow Benefit Inventory was specifically
designed to have both positive and negative outcomes with
the aim of being able to say that following an intervention
x% of patients benefited, y% of patients did not benefit and
z% of patients were worse. Such data could be used to
inform patients of what the likelihood of overall benefit
would be in addition to how successful technically the
intervention was. It would also allow the Glasgow Benefit
Inventory to be used for individual and departmental audit.
What is not known is the range around a zero Glasgow
Benefit Inventory score that would define no positive or
negative benefit. Till this has been defined, what can be
done is to report Glasgow Benefit Inventory outcomes as
distribution plots. Arbitrary cut-off points within a given
case series might then become obvious.
At this stage, it probably would be incorrect to compare
the benefit of interventions that did not have the same
clinical objective such as surgery for hearing versus surgery
for recurrent sore throats. This is because the components
making up the total Glasgow Benefit Inventory score are not
the same. This aspect needs further investigation using up-
to-date statistical methods for factor rather than principal
component analysis.
We have provided a standardised set of representative
outcome scores including distribution of data on five
otolaryngology interventions, with principal component
subscales. As with all representative scores, these are an
average of all patients and surgeons, and therefore, it is
expected these represent a random selection of patients with
good and poor outcomes, as well as surgeons with better and
worse outcomes. Thus, the data from these highly selective
series are unlikely to give the sameGlasgowBenefit Inventory
benefits when applied to overall otorhinolaryngolical
practices.66
Case series are required of interventions yet to be reported,
or reported insufficiently to give usable data. This should
include patients managed non-surgically, with medication,
physical therapy or the supply of devices and include the
above-suggested distribution plots of the data. Such data
would also be of interest to ascertain the area of benefit using
subscore analysis or indeed performing principal compo-
nent analysis. In addition, especially if prospectively
planned, such case series can on multifactorial analysis give
predictions of patient benefit.
Factor analysis is merited of tonsillectomy patients’
responses in comparison with other surgical and non-surgical
interventions to identify variations that could lead to recon-
sideration renaming or reconfiguration of the subscores.
Keypoints
• Glasgow Benefit Inventory is a validated patient-
recorded outcome measure to assess quality of life
post-medical and surgical interventions in otolaryn-
gology albeit to date no medical interventions have
been reported in detail.
• In case series, it can be used to identify predictors of
benefit.
• Subscores can be useful in characterising the areas of
benefit when a comparison is being made between
different interventions where the surgical objectives
might seem similar.
• Although applicable for all otorhinolaryngological
patients, there is sufficient differences in the mean
benefit between six of the 11 surgical interventions for
comparisons to be made between departments or
individual clinicians presumably because of the greatly
varying indications.
• For cochlear implant, middle ear implant, stapes
surgery, tonsillectomy and management of vestibular
schwannoma, there is consistency of data in meta-
analysis to suggest that these interventions can be
compared for audit purposes.
• Higher quality of reporting of the Glasgow Benefit
Inventory data and investigation of non-surgical
interventions are desirable reporting the distribution
of the data to allow percentages that had no or negative
benefit to be reported.
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